Detail akcie Theraclion online

Business Summary: Theraclion SA is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Theraclion SA revenues increased from -EUR238K to EUR834K. Net loss applicable to common stockholders decreased 17% to EUR2.5M. Revenues reflect System Sales segment increase from EUR108K to EUR309K, Sales of Services segment increase from EUR46K to EUR153K. Lower net loss reflects Charges to Provisions decrease from EUR401K (expense) to EUR0K, Other Operating Income/Expense decrease from EUR41K (expense) to EUR0K.